H1B Report
Side-by-side comparison

AMNEAL PHARMACEUTICALS LLC vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
AMNEAL PHARMACEUTICALS LLC
NJRank #FEIN 90-0186021
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricAMNEAL PHARMACEUTICALS LLCDeloitte Consulting LLP
Total filings45380,813
Certified %94.04%98.23%
Denied %0.66%1.09%
Withdrawn %2.65%0.61%
Cert-withdrawn %2.65%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateNJPA

Outcomes — AMNEAL PHARMACEUTICALS LLC

DOL case-status mix.

Outcome breakdown: Certified 94.0%, Cert-withdrawn 2.6%, Withdrawn 2.6%, Denied 0.7%
Outcome breakdown
OutcomeShare
Certified94.0%
Cert-withdrawn2.6%
Withdrawn2.6%
Denied0.7%
Certified94.0%
Cert-withdrawn2.6%
Withdrawn2.6%
Denied0.7%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

AMNEAL PHARMACEUTICALS LLC
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201013
FY201125
FY201225
FY201324
FY201439
FY201551
FY201638
FY201740
FY201838
FY201945
FY20202
FY20216
FY20223
FY202314
FY202434
FY202525
FY202631
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612

Top 5 occupations — AMNEAL PHARMACEUTICALS LLC

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.